- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 7, 2025 | 101.95M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $953M |
| Long Term Debt | Q1 2025 · Sep 30, 2024 | $994M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $105.53M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $107.96M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $548.6M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $592.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.05B |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $2.16B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Current Assets | Q1 2025 · Sep 30, 2024 | $1.31B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.71B |
| Total Assets | Q1 2025 · Sep 30, 2024 | $2.79B |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 108.72M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $20.2M |
| Capex | Q1 2025 · Dec 31, 2023 | $30.55M |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $51.02M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $541.34M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $508.75M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.35 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.36 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $398.14M |
| Net Income | Q1 2025 · Dec 31, 2023 | $38.39M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $69.12M |
| Gross Profit | Q1 2025 · Dec 31, 2023 | $467.18M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $464.13M |
| Revenue | Q1 2025 · Dec 31, 2023 | $931.3M |